These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 709913)

  • 1. Inhibition of lymphocyte cytotoxicity in chronic active hepatitis.
    Kakumu S; Hara T; Gohji H; Sakamoto N
    Clin Exp Immunol; 1978 Jul; 33(1):71-8. PubMed ID: 709913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG.antibody-dependent cell-mediated cytotoxicity against cultured liver cells in patients with chronic active hepatitis.
    Nonomura A; Shintani T; Ohta G
    Jpn J Exp Med; 1978 Oct; 48(5):381-92. PubMed ID: 748618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.
    Vierling JM; Nelson DL; Strober W; Bundy DM; Jones EA
    J Clin Invest; 1977 Nov; 60(5):1116-28. PubMed ID: 332716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immunity in acute and chronic hepatitis.
    Wands JR; Perrotto JL; Alpert E; Isselbacher KJ
    J Clin Invest; 1975 May; 55(5):921-9. PubMed ID: 1079030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LM-Ag and LSP--two different target antigens involved in the immunopathogenesis of chronic active hepatitis?
    Meyer zum Büschenfelde KH; Manns M; Hütteroth TH; Hopf U; Arnold W
    Clin Exp Immunol; 1979 Aug; 37(2):205-12. PubMed ID: 498582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against human liver-specific protein (LSP) in acute and chronic viral hepatitis types A, B and non-A, non-B.
    Meliconi R; Baraldini M; Stefanini GF; Facchini A; Miglio F; Bortolotti F; Alberti A; Realdi G; Amoroso P
    Clin Exp Immunol; 1981 Nov; 46(2):382-90. PubMed ID: 6802539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte transformation test with rabbit liver specific lipoprotein (RLSP) in chronic active hepatitis.
    Ortona L; Laghi V; Cauda R; Nervo P
    Clin Exp Immunol; 1979 Nov; 38(2):231-4. PubMed ID: 527260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct and serum-induced lymphocytotoxicity against rabbit hepatocytes in chronic active hepatitis.
    Ortona L; Laghi V; Cauda R; Nervo P
    Boll Ist Sieroter Milan; 1981; 60(1):46-51. PubMed ID: 7272012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-dependent cell-mediated cytotoxicity (ADCC) and cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells in patients with hepatitis B and chronic hepatitis (CAH).
    Warnatz H; Rösch W; Gerlich W; Gutmann W
    Clin Exp Immunol; 1979 Jan; 35(1):133-40. PubMed ID: 371882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of antibodies against rabbit liver specific lipoprotein (RLSP) in chronic active hepatitis.
    Ortona L; Laghi V; Tamburrini E; Troncone L; Bonifazi N; Nervo P; Cauda R
    Clin Exp Immunol; 1983 May; 52(2):437-40. PubMed ID: 6861379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro cell-mediated cytotoxicity for autologous liver cells in chronic non-A, non-B hepatitis.
    Mondelli M; Alberti A; Tremolada F; Williams R; Eddleston AL; Realdi G
    Clin Exp Immunol; 1986 Jan; 63(1):147-55. PubMed ID: 3082546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Direct and induced lymphocytotoxicity to rabbit hepatocytes in chronic active hepatitis].
    Laghi V; Cauda R; Nervo P
    Arch Sci Med (Torino); 1980; 137(4):575-7. PubMed ID: 7247672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis.
    Vergani GM; Vergani D; Jenkins PJ; Portmann B; Mowat AP; Eddleston AL; Williams R
    Clin Exp Immunol; 1979 Oct; 38(1):16-21. PubMed ID: 393438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The IgG antibody reactivity of sera from patients with active chronic hepatitis to a crude liver antigen and liver specific protein (LSP): analysis by ELISA and immunoblotting.
    Sundin U; Heigl Z; Sundqvist KG
    Clin Exp Immunol; 1988 Nov; 74(2):276-82. PubMed ID: 3265656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody dependent cellular cytotoxicity (ADCC) in acute hepatitis B and in chronic active hepatitis.
    Bortolotti F; Realdi G; Diodati G; Fattovich G
    Clin Exp Immunol; 1978 Aug; 33(2):211-6. PubMed ID: 719950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Anti-Ia reactivity in sera from patients with chronic active hepatitis (CAH)".
    Levrero M; Barnaba V; Paroli M; Valesini G; Franco A; Laghi V; Cauda R; Balsano F
    J Clin Lab Immunol; 1987 Oct; 24(2):63-8. PubMed ID: 2963916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro studies on IgG-mediated lymphocyte cytotoxicity in chronic active liver disease.
    Kawanishi H
    Gastroenterology; 1977 Sep; 73(3):549-55. PubMed ID: 892355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte cytotoxicity in alcoholic hepatitis.
    Kakumu S; Leevy CM
    Gastroenterology; 1977 Apr; 72(4 Pt 1):594-7. PubMed ID: 65306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating complement fixing immune complexes in chronic hepatitis. Use of anti-C3 enzyme immunoassay to define antibody class and nature of antigen.
    Sagnelli E; Felaco FM; Triolo G; Vernace SJ; Filippini P; Piccinino F; Behrens U; Paronetto F
    J Clin Lab Immunol; 1983 Sep; 12(1):11-5. PubMed ID: 6195340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to ribosomes in chronic active hepatitis.
    Gerber MA; Shapiro JM; Smith H; Lebwohl O; Schaffner F
    Gastroenterology; 1979 Jan; 76(1):139-43. PubMed ID: 758135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.